CN1362956A - C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂 - Google Patents

C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂 Download PDF

Info

Publication number
CN1362956A
CN1362956A CN01800316A CN01800316A CN1362956A CN 1362956 A CN1362956 A CN 1362956A CN 01800316 A CN01800316 A CN 01800316A CN 01800316 A CN01800316 A CN 01800316A CN 1362956 A CN1362956 A CN 1362956A
Authority
CN
China
Prior art keywords
pyridyl
furyl
thienyl
taxane
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01800316A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·霍尔顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Publication of CN1362956A publication Critical patent/CN1362956A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
CN01800316A 2000-02-02 2001-02-02 C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂 Pending CN1362956A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17967000P 2000-02-02 2000-02-02
US60/179,670 2000-02-02

Publications (1)

Publication Number Publication Date
CN1362956A true CN1362956A (zh) 2002-08-07

Family

ID=22657498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01800316A Pending CN1362956A (zh) 2000-02-02 2001-02-02 C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂

Country Status (23)

Country Link
US (3) US6359154B2 (https=)
EP (1) EP1165549B1 (https=)
JP (1) JP2003522168A (https=)
KR (1) KR20020002417A (https=)
CN (1) CN1362956A (https=)
AT (1) ATE392422T1 (https=)
AU (1) AU778991B2 (https=)
BR (1) BR0104355A (https=)
CA (1) CA2368510A1 (https=)
CZ (1) CZ20013521A3 (https=)
DE (1) DE60133600T2 (https=)
DK (1) DK1165549T3 (https=)
ES (1) ES2305056T3 (https=)
HK (1) HK1047937A1 (https=)
HU (1) HUP0200752A3 (https=)
IL (1) IL145643A0 (https=)
MX (1) MXPA01009923A (https=)
NO (1) NO20014757L (https=)
NZ (1) NZ514410A (https=)
PL (1) PL350024A1 (https=)
PT (1) PT1165549E (https=)
WO (1) WO2001057028A1 (https=)
ZA (1) ZA200108056B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019170092A1 (zh) * 2018-03-06 2019-09-12 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其缀合物、含有缀合物的纳米制剂及其制备方法及应用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1047937A1 (zh) * 2000-02-02 2003-03-14 佛罗里达州立大学研究基金有限公司 C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂
CA2367661A1 (en) * 2000-02-02 2001-08-09 Robert A. Holton Taxane formulations having improved solubility
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
BR0313197A (pt) 2002-08-02 2005-08-09 Immunogen Inc Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
DK0552041T3 (da) 1992-01-15 2000-10-09 Squibb & Sons Inc Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fr
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
CA2109861C (en) 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
ATE253563T1 (de) * 1993-02-05 2003-11-15 Bryn Mawr College Synthese von taxol, seinen analogen und intermediaten mit variablen a-ring seitenketten
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
US6100411A (en) 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
EP0788493A1 (en) 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
WO1997009979A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
AU724499B2 (en) 1996-05-06 2000-09-21 Florida State University 1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
HK1047937A1 (zh) * 2000-02-02 2003-03-14 佛罗里达州立大学研究基金有限公司 C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019170092A1 (zh) * 2018-03-06 2019-09-12 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其缀合物、含有缀合物的纳米制剂及其制备方法及应用
CN110227164B (zh) * 2018-03-06 2021-11-23 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其缀合物、含有缀合物的纳米制剂及其制备方法及应用
CN113952464A (zh) * 2018-03-06 2022-01-21 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其应用
US11833128B2 (en) 2018-03-06 2023-12-05 Jiangsu Jibeier Pharmaceutical Co. Ltd. Ketone carbonyl-containing hydrophobic antitumor drug and conjugate thereof as well as nano preparation containing conjugate, preparation method therefor, and application thereof
CN113952464B (zh) * 2018-03-06 2024-10-15 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其应用

Also Published As

Publication number Publication date
CA2368510A1 (en) 2001-08-09
EP1165549A1 (en) 2002-01-02
DK1165549T3 (da) 2008-08-11
US6359154B2 (en) 2002-03-19
AU778991B2 (en) 2004-12-23
US20030060638A1 (en) 2003-03-27
DE60133600T2 (de) 2009-06-10
ES2305056T3 (es) 2008-11-01
BR0104355A (pt) 2002-01-02
HK1047937A1 (zh) 2003-03-14
NO20014757D0 (no) 2001-10-01
MXPA01009923A (es) 2003-08-01
EP1165549B1 (en) 2008-04-16
ZA200108056B (en) 2003-12-01
DE60133600D1 (de) 2008-05-29
JP2003522168A (ja) 2003-07-22
ATE392422T1 (de) 2008-05-15
PL350024A1 (en) 2002-10-21
US20010051640A1 (en) 2001-12-13
US20050020635A1 (en) 2005-01-27
AU3330201A (en) 2001-08-14
HUP0200752A3 (en) 2005-02-28
US6750245B2 (en) 2004-06-15
NZ514410A (en) 2005-01-28
WO2001057028A1 (en) 2001-08-09
HUP0200752A2 (en) 2002-10-28
PT1165549E (pt) 2008-06-20
KR20020002417A (ko) 2002-01-09
NO20014757L (no) 2001-11-29
CZ20013521A3 (cs) 2002-03-13
IL145643A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
CN1362955A (zh) 作为抗肿瘤剂的c7酯取代的紫杉烷
US6664275B2 (en) C10 heterosubstituted acetate taxanes
CN1186340C (zh) 用作抗肿瘤剂的c10碳酸酯取代的紫杉烷
US6673833B2 (en) C7 heterosubstituted acetate taxanes
CN1362958A (zh) 用作抗肿瘤剂的c7碳酸酯取代的紫杉烷
CN1362959A (zh) C10氨基甲酰氧基取代的紫衫烷抗肿瘤剂
CN1362956A (zh) C7氨基甲酰氧基取代的紫衫烷抗肿瘤剂
CN1380882A (zh) 作为抗肿瘤剂的c10酯取代的紫杉烷
US20050209311A1 (en) C7 lactyloxy-substituted taxanes
HK1049670A (en) C10 ester substituted taxanes as antitumor agents
HK1053472B (en) C10 carbonate substituted taxanes as antitumor agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1047937

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication